Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years

More on Reevaluating PSA Testing Rates in the PLCO Trial

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Reevaluating PSA Testing Rates in the PLCO Trial

(2016) Jonathan E. Shoag et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

(2016) Freddie C. Hamdy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

(2010) Paul F Pinsky et al.   Clinical Trials

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE